Did you find this information helpful?
Mapstabine 500mg Tablet
Salt Composition : Capecitabine
Manufacturer : AMPS BIOTECH PVT LTD
Origin of Medicine : India
10 Tablet(s) In A Strip
Introduction to Mapstabine 500mg Tablet
Mapstabine 500mg Tablet contains the active ingredient Capecitabine. It belongs to the category of medicines known as antimetabolites. This medication is used in combination with other anticancer drugs for the treatment of Metastatic colorectal cancer and breast cancer. Cancer is a disease in which cells multiply in an abnormal and uncontrolled manner. It is also used for the prevention of new occurrences of cancer in the colon after the complete removal of the tumor by surgery.
The common side effects that are likely to occur with this medicine are loss of appetite, headache, runny nose, fever, hair loss, and dry mouth. During the treatment, your doctor may periodically monitor your complete blood counts, prothrombin time, INR, to prevent serious complications. Report to your doctor if you have been diagnosed with stomach ulcers, cataract, lung disease, problems in your heart, liver, skin, kidneys. Tell your physician before you undergo eye surgery or dental procedures. Inform your doctor if you have experienced any allergic or unusual reactions after taking this tablet. This medicine can cause fertility issues, inform your doctor about any fertility concerns you may have before starting treatment with this medicine.
Mapstabine 500mg Tablet is not recommended for children and adolescents. Before taking this medicine, ask for physician advice if you are intolerant to sugars as this chemotherapy medication contains lactose. This drug will not be given if you have low white blood cell or platelet count, chickenpox, shingles, or enzyme DPD deficiency (dihydropyrimidine dehydrogenase). Take this medicine within thirty minutes after finishing a meal. This drug can cause fetal harm when administered to a pregnant woman
Uses of Mapstabine 500mg Tablet
Mapstabine 500mg is used to treat,
- Adjuvant colon cancer
- Metastatic colorectal cancer
- Metastatic breast cancer
Therapeutic Effects of Mapstabine 500mg Tablet
Mapstabine 500mg is prescribed alone and also in combination with other anticancer medications like Docetaxel and Oxaliplatin. It stops the growth of cancer cells by inhibiting DNA synthesis. Mapstabine 500mg gets converted into its active form called fluorouracil and interferes with cell signaling, ultimately preventing the multiplication of cancer cells.
Interaction of Mapstabine 500mg Tablet with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Mapstabine 500mg Tablet and reduce effectiveness by causing undesirable side effects.
More Information about Mapstabine 500mg Tablet
- Store Mapstabine 500mg Tablet in the original package at room temperature (20°C to 25°C). Do not freeze.
- Keep it out of reach from children and pets.
- It is important to get the dose at the scheduled time. If you missed the schedule, contact your doctor and reschedule the dose.
How to consume Mapstabine 500mg Tablet
Take a Mapstabine 500mg Tablet as prescribed by your doctor. Do not crush or chew the tablet. If you miss a dose of this tablet, take it as soon as you can if it is within 12 hours of the missed dose. If it is over 12 hours since your missed dose, skip the missed dose and go back to your usual dosing times to avoid taking double doses. Call your doctor to ask about making up the missed dose.
Safety Advices for Mapstabine 500mg Tablet
Mapstabine 500mg Tablet is not recommended for pregnant women as it may cause fetal harm.
It is not known if Mapstabine 500mg passes into your breast milk or if it will affect your baby or your breast milk. Talk to your doctor about the best way to feed your baby if you receive this drug.
It is not known whether Mapstabine 500mg can be prescribed to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Inform your doctor if you have any liver disorders before taking Mapstabine 500mg. Regular monitoring of liver function tests is recommended.
It is unknown whether consuming alcohol interacts with Mapstabine 500mg. Please consult your doctor for more advice.
Mapstabine 500mg Tablet may cause drowsiness which can affect the patient’s ability to drive or use machines. Consult your doctor before you resume driving.
Side Effects of Mapstabine 500mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
- Severe bloody diarrhoea, abdominal pain
- Heart problems (chest pain, shortness of breath, feeling faint, irregular heartbeat, sudden weight gain)
- Loss of too much body fluid, kidney failure
- Serious skin and mouth reactions (skin peeling, blisters)
- Hand and foot syndrome (swelling, changes in sensation of hands and feet)
- Liver problems
- Decreased blood count
- Loss of appetite
- Weight loss
- Insomnia, depression
- Headache, dizziness
- Eye irritation, redness, increased tears
- Inflammation of veins
- Runny nose, fever
- Hair loss
- Pain in joints, back
- Dry mouth, indigestion
Word of Advice
Mapstabine 500mg Tablet causes skin dryness so it is advised to use an effective moisturiser for your skin. Ensure that you stay hydrated and maintain a balanced diet. Store the drug in the original package at room temperature (25°C). Do not freeze. Keep it out of reach from children and pets. It is important to get the dose at the scheduled time. If you missed the schedule, contact your doctor and reschedule the dose. Avoid driving or operating heavy machines if you experience dizziness, nausea, or tiredness while on treatment with Mapstabine 500mg.
Q 1. Is Mapstabine 500mg prescribed as a monotherapy?
Mapstabine 500mg is prescribed as a monotherapy and also in combination with other anticancer agents like Docetaxel and Oxaliplatin to treat breast and colorectal cancer respectively.
Q 2. What tests are essential before starting treatment with Mapstabine 500mg?
Before starting treatment with Mapstabine 500mg, your healthcare provider will recommend tests for pregnancy, DPD deficiency (dihydropyrimidine dehydrogenase), prothrombin time, INR, kidney function tests and serum electrolytes.
Q 3. Is it safe to undergo surgery during the treatment with Mapstabine 500mg?
It is suggested to avoid planning for surgery while on treatment with Mapstabine 500mg. Tell your physician before you undergo surgery or dental procedures.
Q 4. What should you do if you missed a dose of Mapstabine 500mg?
If you missed taking a dose of Mapstabine 500mg Tablet, skip this dose. Do not take two tablets to make up for the missed dose. Report to your healthcare provider right away if you missed taking more than two doses of Mapstabine 500mg.
Q 5. Who should not take Mapstabine 500mg?
Mapstabine 500mg is not recommended for people who are allergic to Mapstabine 500mg, 5-fluorouracil and their ingredients. It is also contraindicated in people with severe kidney disease and DPD deficiency (dihydropyrimidine dehydrogenase).
Q 6. Can you smoke while on treatment with Mapstabine 500mg?
It is not recommended to smoke cigarettes while on treatment with Mapstabine 500mg as smoking can reduce the concentration of Mapstabine 500mg in the body.
Q 7. How do you know if you have overdosed on Mapstabine 500mg?
Watch out for symptoms like nausea, gastric irritation, diarrhea, vomiting, and bleeding, and seek immediate medical attention from a nearby healthcare facility.
Fact Box of Mapstabine 500mg Tablet
Molecule name: Capecitabine
Therapeutic class: Anti-metabolite
Pharmacological class: Nucleoside metabolic inhibitor
1.Adjuvant colon cancer
2. Metastatic colorectal cancer
3. Metastatic breast cancer
- Morningside Healthcare Ltd, Electronic medicines compendium (emc), [ Revised on Feb 2021] [ Accessed on 9th March 2023], https://www.medicines.org.uk/emc/files/pil.11498.pdf
- Genentech USA, Inc, US Food and Drug Administration, [ Revised on March 2015] [ Accessed on 9th March 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020896s037lbl.pdf
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 864.
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1698.
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.
100% secure and trusted payment protection
We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.